Clinical trial
Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients…
NCT00309335 · Novalar Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00309335 |
|---|---|
| Title | Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Maxillary Procedures |
| Official title | A Phase 3, Multicenter, Randomized, Blinded, Controlled Study of NV-101 for Efficacy, Pharmacodynamics and Safety in Dental Patients Undergoing Maxillary Procedures |
| Lead sponsor | Novalar Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anesthesia, Dental |
| Intervention type | Drug |
| Interventions | Phentolamine Mesylate (NV-101) |
| Enrollment | 240 |
| Start date | Feb 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Mar 31, 2006 |
| Last update posted | Nov 17, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: